Last 12 months
Inside the activity.
0 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 23, 2018 Filed Jul 23, 2018 21:18 UTC |
Cesario Douglas ACFO and Secretary
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,195,073 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001209191-18-043633 · doc4.xml · derivative · entry 2 Cesario Douglas A · CIK 0001738287 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,195,073 Underlying: Common Stock · 1,195,073 shares Expires 2028-07-23 F2 · derivative.exercise_date: 25% of the total number of shares subject to the option shall vest and become exercisable on July 23, 2018, and the remaining 75% of the total number of shares subject to the option shall vest and become exercisable 1/33rd on each of the next 33 months thereafter. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 21:18 UTC |
Cesario Douglas ACFO and Secretary
|
GrantCommon Stock | 643,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043633 · doc4.xml · nonDerivative · entry 1 Cesario Douglas A · CIK 0001738287 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,501 F1 · kind: 100% of the restricted stock award shall vest and be deliverable on April 23, 2020. Read SEC document |
| March 29, 2018 Filed Apr 4, 2018 01:10 UTC |
Emerald Health Sciences Inc.10% owner
|
ConversionSeries F Convertible Preferred Stock · Derivative | 2,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001209191-18-023388 · doc4.xml · derivative · entry 4 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Series F Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date. F2 · derivative.expiration_date: The Series F Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date. Read SEC document |
| March 29, 2018 Filed Apr 4, 2018 01:10 UTC |
Emerald Health Sciences Inc.10% owner
|
ConversionSeries B Convertible Preferred Stock · Derivative | 1,233.5 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001209191-18-023388 · doc4.xml · derivative · entry 3 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,335,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Series B Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date. F1 · derivative.expiration_date: The Series B Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date. Read SEC document |
| March 29, 2018 Filed Apr 4, 2018 01:10 UTC |
Emerald Health Sciences Inc.10% owner
|
ConversionCommon Stock | 20,000,000 | $0.10 | $2,000,000.00 |
DisclosureSEC source: 0001209191-18-023388 · doc4.xml · nonDerivative · entry 2 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,116,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 4, 2018 01:10 UTC |
Emerald Health Sciences Inc.10% owner
|
ConversionCommon Stock | 12,335,000 | $0.10 | $1,233,500.00 |
DisclosureSEC source: 0001209191-18-023388 · doc4.xml · nonDerivative · entry 1 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,116,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:32 UTC |
Emerald Health Sciences Inc.10% owner
|
PurchaseCommon Stock Warrants (right to buy) · Derivative | 20,400,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001209191-18-011938 · doc4.xml · derivative · entry 2 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,400,000 Underlying: Common Stock · 20,400,000 shares Expires 2023-02-16 F1 · kind: The reporting person purchased in a private placement 15,000,000 shares (the "Shares") of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), and a warrant (the "Warrant") to purchase 20,400,000 shares of Common Stock at an exercise price of $0.10 per share. The Shares and the Warrant were purchased as a unit at $.10 per unit. F1 · price: The reporting person purchased in a private placement 15,000,000 shares (the "Shares") of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), and a warrant (the "Warrant") to purchase 20,400,000 shares of Common Stock at an exercise price of $0.10 per share. The Shares and the Warrant were purchased as a unit at $.10 per unit. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:32 UTC |
Emerald Health Sciences Inc.10% owner
|
PurchaseCommon Stock | 15,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-011938 · doc4.xml · nonDerivative · entry 1 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000,000 F1 · kind: The reporting person purchased in a private placement 15,000,000 shares (the "Shares") of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), and a warrant (the "Warrant") to purchase 20,400,000 shares of Common Stock at an exercise price of $0.10 per share. The Shares and the Warrant were purchased as a unit at $.10 per unit. F1 · price: The reporting person purchased in a private placement 15,000,000 shares (the "Shares") of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), and a warrant (the "Warrant") to purchase 20,400,000 shares of Common Stock at an exercise price of $0.10 per share. The Shares and the Warrant were purchased as a unit at $.10 per unit. Read SEC document |
| January 24, 2018 Filed Mar 3, 2018 00:46 UTC |
Emerald Health Sciences Inc.10% owner
|
OtherCommon Stock Warrant (Right to Buy) · Derivative | 1,781,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016047 · doc4.xml · derivative · entry 2 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,781,250 shares Expires 2020-08-20 Read SEC document |
| January 24, 2018 Filed Mar 3, 2018 00:46 UTC |
Emerald Health Sciences Inc.10% owner
|
OtherCommon Stock | 1,781,250 | $0.00 | $1,781.25 |
DisclosureSEC source: 0001209191-18-016047 · doc4.xml · nonDerivative · entry 1 Emerald Health Sciences Inc. · CIK 0001728413 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,781,250 Read SEC document |
| March 13, 2017 Filed Mar 28, 2017 14:52 UTC |
Lapham Reg Alexander10% owner
|
OtherCommon Stock | 119,700 | $1.00 | $119,700.00 |
DisclosureSEC source: 0001140361-17-013540 · doc1.xml · nonDerivative · entry 1 Lapham Reg Alexander · CIK 0001624201 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,787,500 F1 · shares: The shares of common stock were transferred to a creditor as repayment of outstanding principal and accrued interest of certain promissory note upon maturity pursuant to the terms of such note. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.